Raymond James Trust’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-27,763
Closed -$2.76M 994
2019
Q3
$2.76M Sell
27,763
-1,005
-3% -$95.5K 0.14% 144
2019
Q2
$2.66M Sell
28,768
-594
-2% -$56.4K 0.15% 144
2019
Q1
$2.77M Sell
29,362
-5,094
-15% -$446K 0.16% 135
2018
Q4
$2.21M Sell
34,456
-1,619
-4% -$120K 0.14% 151
2018
Q3
$3.23M Buy
36,075
+2,853
+9% +$252K 0.18% 123
2018
Q2
$2.64M Sell
33,222
-1,092
-3% -$90.7K 0.16% 138
2018
Q1
$3.06M Buy
34,314
+437
+1% +$42K 0.21% 110
2017
Q4
$3.54M Buy
33,877
+1,439
+4% +$162K 0.24% 99
2017
Q3
$4.73M Buy
32,438
+2,306
+8% +$314K 0.34% 77
2017
Q2
$3.91M Buy
30,132
+5,329
+21% +$653K 0.29% 91
2017
Q1
$3.09M Sell
24,803
-1,795
-7% -$215K 0.23% 104
2016
Q4
$3.08M Buy
26,598
+8,814
+50% +$982K 0.25% 100
2016
Q3
$1.86M Buy
17,784
+1,383
+8% +$150K 0.16% 138
2016
Q2
$1.62M Buy
16,401
+338
+2% +$35K 0.14% 152
2016
Q1
$1.61M Sell
16,063
-2,683
-14% -$276K 0.15% 143
2015
Q4
$2.25M Buy
18,746
+3,660
+24% +$423K 0.21% 113
2015
Q3
$1.63M Buy
15,086
+153
+1% +$19K 0.18% 124
2015
Q2
$1.73M Sell
14,933
-1,435
-9% -$164K 0.18% 129
2015
Q1
$1.89M Sell
16,368
-1,085
-6% -$130K 0.2% 119
2014
Q4
$1.95M Sell
17,453
-725
-4% -$76.5K 0.21% 113
2014
Q3
$1.72M Buy
18,178
+8,486
+88% +$766K 0.2% 115
2014
Q2
$832K Sell
9,692
-9,238
-49% -$703K 0.1% 211
2014
Q1
$1.32M Sell
18,930
-458
-2% -$36.3K 0.16% 132
2013
Q4
$1.64M Buy
19,388
+294
+2% +$23.3K 0.22% 111
2013
Q3
$1.47M Buy
19,094
+2,910
+18% +$204K 0.23% 109
2013
Q2
$946K Buy
+16,184
New +$974K 0.15% 145

Other funds holding CELG

Raymond James Trust's CELG Position: Q4 2019 in Review

Raymond James Trust sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 27,763 shares — an estimated $2.76M sold.

Raymond James Trust first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $4.73M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Raymond James Trust reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Raymond James Trust sold 27,763 Celgene Corp shares in Q4 2019, an estimated $2.76M.
  • Raymond James Trust first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Raymond James Trust's Celgene Corp position peaked at $4.73M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Raymond James Trust's 13F filing for Q4 2019, filed 14 Jan 2020.